120 related articles for article (PubMed ID: 26842385)
1. A Man With Persistent Dopamine Agonist Withdrawal Syndrome After 7 Years Being Off Dopamine Agonists.
Huynh NT; Sid-Otmane L; Panisset M; Huot P
Can J Neurol Sci; 2016 Nov; 43(6):859-860. PubMed ID: 26842385
[No Abstract] [Full Text] [Related]
2. Dopamine agonist withdrawal syndrome: A comprehensive review.
Yu XX; Fernandez HH
J Neurol Sci; 2017 Mar; 374():53-55. PubMed ID: 28104232
[TBL] [Abstract][Full Text] [Related]
3. Suicide attempt in a dopamine agonist withdrawal syndrome in Parkinson's disease.
Espindola M; Rojas NG; Vaisentein G; Da Prat G; Cesarini M; Etcheverry JL; Gatto EM
Parkinsonism Relat Disord; 2024 Apr; 121():106017. PubMed ID: 38401377
[TBL] [Abstract][Full Text] [Related]
4. Dopamine Agonist Withdrawal Syndrome and Suicidality in Parkinson's Disease.
Kwan C; Kolivakis T; Huot P
Can J Neurol Sci; 2023 Sep; 50(5):779-780. PubMed ID: 35801613
[No Abstract] [Full Text] [Related]
5. Dopamine agonist withdrawal syndrome (DAWS): perils of flicking the dopamine 'switch'.
Edwards MJ
J Neurol Neurosurg Psychiatry; 2013 Feb; 84(2):120. PubMed ID: 22993451
[No Abstract] [Full Text] [Related]
6. Clinical features of dopamine agonist withdrawal syndrome in a movement disorders clinic.
Pondal M; Marras C; Miyasaki J; Moro E; Armstrong MJ; Strafella AP; Shah BB; Fox S; Prashanth LK; Phielipp N; Lang AE
J Neurol Neurosurg Psychiatry; 2013 Feb; 84(2):130-5. PubMed ID: 22933817
[TBL] [Abstract][Full Text] [Related]
7. Dopamine agonist withdrawal syndrome in Parkinson's disease.
Solla P; Fasano A; Cannas A; Marrosu F
J Neurol Sci; 2017 Nov; 382():47-48. PubMed ID: 29111017
[No Abstract] [Full Text] [Related]
8. Identification of possible risk factors for the development of dopamine agonist withdrawal syndrome in Parkinson's disease.
Cunnington AL; White L; Hood K
Parkinsonism Relat Disord; 2012 Nov; 18(9):1051-2. PubMed ID: 22677468
[No Abstract] [Full Text] [Related]
9. Dopamine agonist withdrawal syndrome in a patient with restless legs syndrome.
Dorfman BJ; Nirenberg MJ
Parkinsonism Relat Disord; 2013 Feb; 19(2):269-70. PubMed ID: 22749683
[No Abstract] [Full Text] [Related]
10. Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation.
Thobois S; Ardouin C; Lhommée E; Klinger H; Lagrange C; Xie J; Fraix V; Coelho Braga MC; Hassani R; Kistner A; Juphard A; Seigneuret E; Chabardes S; Mertens P; Polo G; Reilhac A; Costes N; LeBars D; Savasta M; Tremblay L; Quesada JL; Bosson JL; Benabid AL; Broussolle E; Pollak P; Krack P
Brain; 2010 Apr; 133(Pt 4):1111-27. PubMed ID: 20237128
[TBL] [Abstract][Full Text] [Related]
11. Developments in impulse control behaviours of Parkinson's disease.
Zurowski M; O'Brien JD
Curr Opin Neurol; 2015 Aug; 28(4):387-92. PubMed ID: 26110803
[TBL] [Abstract][Full Text] [Related]
12. Increased creativity associated with dopamine agonist therapy: A case report and short review of the literature.
Thakolwiboon S; Karukote A; Julayanont P; Wilms H
Clin Neurol Neurosurg; 2022 May; 216():107237. PubMed ID: 35395562
[TBL] [Abstract][Full Text] [Related]
13. Suicide without depression after withdrawal of a dopamine agonist in a patient with Parkinson's disease.
Flament M; Loas G; Godefroy O; Krystkowiak P
J Neuropsychiatry Clin Neurosci; 2011; 23(4):E32. PubMed ID: 22231340
[No Abstract] [Full Text] [Related]
14. Dopamine agonist withdrawal syndrome and non-motor symptoms after Parkinson's disease surgery.
Nirenberg MJ
Brain; 2010 Nov; 133(11):e155; author reply e156. PubMed ID: 20659959
[No Abstract] [Full Text] [Related]
15. Dopamine agonist withdrawal syndrome: implications for patient care.
Nirenberg MJ
Drugs Aging; 2013 Aug; 30(8):587-92. PubMed ID: 23686524
[TBL] [Abstract][Full Text] [Related]
16. [Impulse control disorders associated with dopaminergic agonists in Parkinson's disease. Case report].
Gamboa Arango A; Bernal Bernal MT; Duaso Magaña E
Rev Esp Geriatr Gerontol; 2016; 51(5):304-5. PubMed ID: 27016028
[No Abstract] [Full Text] [Related]
17. Prevention of Dopamine Dysregulation Syndrome in Parkinson's Disease: A Case Report.
Luchsinger WT; Gambhir N; DeMoss D
Prim Care Companion CNS Disord; 2018 Apr; 20(2):. PubMed ID: 29701928
[No Abstract] [Full Text] [Related]
18. Resolution of dopamine dysregulation syndrome following cessation of dopamine agonist therapy in Parkinson's disease.
Kimber TE; Thompson PD; Kiley MA
J Clin Neurosci; 2008 Feb; 15(2):205-8. PubMed ID: 18068992
[TBL] [Abstract][Full Text] [Related]
19. Dopamine agonist withdrawal syndrome in a patient with restless legs syndrome without impulse control disorder or drug abuse.
Shimo Y; Nakajima A; Hattori N
Neurol Sci; 2015 Jun; 36(6):1021-3. PubMed ID: 25362251
[No Abstract] [Full Text] [Related]
20. Dopamine agonist withdrawal syndrome (DAWS) symptoms in Parkinson's disease patients treated with levodopa-carbidopa intestinal gel infusion.
Solla P; Fasano A; Cannas A; Mulas CS; Marrosu MG; Lang AE; Marrosu F
Parkinsonism Relat Disord; 2015 Aug; 21(8):968-71. PubMed ID: 26071817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
